What type of drug is codeine phosphate

Giving up codeine after a long time is challenging because the body has to get used to functioning without it. Please seek advice from a health professional. Withdrawal symptoms usually start within a few hours after the last dose and become strongest between 48 and 72 hours. If your use of Codeine is affecting your health, family, relationships, work, school, financial or other life situations, you can find help and support. Not sure what you are looking for?

Try our intuitive Path2Help tool and be matched with support information and services tailored to you. Last published: November 10, What is codeine? Codeine is an opioid. Codeine is used for relief from various conditions, including: mild to moderate pain severe pain when combined with aspirin or paracetamol dry irritating cough diarrhoea cold and flu when combined with antihistamines and decongestants.

I am worried that my teenager might be using drugs What should I do if I find out that my child is using drugs Intervention Talk about drugs and new drug trends For teens Cannabis Know the score The teen brain Worried about someone For teens: Drugs and mental health Getting help Drug trend updates and warnings.

About alcohol What is alcohol? Alcohol diary Alcohol use Balance Sheet Change Plan worksheet Goal Setting Guidelines for supporters How to stick to your plans Tips for drinking less What to do about boredom Young people and drink Why young people drink What are the signs and effects? Concerned parents Children affected by a parent's drinking Alcohol and Cancer Worried about someone? When a loved one has a drink problem What can I do to help?

Coping with a partner's drinking How drink can affect families Looking for help? What you can expect when you look for help Find a service. You are here: Home » Types of Drugs » Codeine phosphate. Using Trusted Resources. Coronavirus Information for Patients. Clinical Trials during Coronavirus. Adolescents and Young Adults with Cancer. Emotional Support for Young People with Cancer. Cancers by Body Location. Late Effects of Childhood Cancer Treatment.

Pediatric Supportive Care. Rare Cancers of Childhood Treatment. Childhood Cancer Genomics. Study Findings. Metastatic Cancer Research.

Intramural Research. Extramural Research. Cancer Research Workforce. Partners in Cancer Research. What Are Cancer Research Studies. Research Studies. Get Involved. Cancer Biology Research. Cancer Genomics Research. Research on Causes of Cancer. Cancer Prevention Research. Cancer Treatment Research. Cancer Health Disparities. Childhood Cancers Research. Global Cancer Research.

Cancer Research Infrastructure. Clinical Trials. Frederick National Laboratory for Cancer Research. Bioinformatics, Big Data, and Cancer. Annual Report to the Nation. Acute ulcerative colitis ; antibiotic-associated colitis ; children under 18 years who undergo the removal of tonsils or adenoids for the treatment of obstructive sleep apnoea ; conditions where abdominal distension develops ; conditions where inhibition of peristalsis should be avoided ; known ultra-rapid codeine metabolisers.

Acute abdomen ; cardiac arrhythmias ; gallstones ; not recommended for adolescents aged 12—18 years with breathing problems. The capacity to metabolise codeine to morphine can vary considerably between individuals; there is a marked increase in morphine toxicity in patients who are ultra-rapid codeine metabolisers CYP2D6 ultra-rapid metabolisers and a reduced therapeutic effect in poor codeine metabolisers.

Biliary spasm ; hypothermia ; mood altered ; postural hypotension ; sexual dysfunction ; ureteral spasm. With oral use. Manufacturer advises avoid recommendation also supported by MHRA and specialist sources. Present in milk and mothers vary considerably in their capacity to metabolise codeine; risk of opioid toxicity in infant. With intramuscular use.